by In2Pharma | Mar 28, 2023 | News
Belgium As from the start of 2023, a new system for funding market surveillance of medical devices by FAMHP applies. Unlike before, this will no longer be limited to the sale of medical devices to retailers and end users. All actors that carry out an activity...
by In2Pharma | Feb 16, 2022 | News
The Netherlands On 1 January 2022, a new provision will be added to the chapter in the GMH* Code regarding transparency. This provision relates to the clarifying note that the GMH foundation publishes annually at the time of publication of the reports by the...
by In2Pharma | Jul 7, 2020 | News
Belgium In anticipation of the European regulations on medical devices and in vitro diagnostic medical devices, the FAMHP has updated the “My company” and “My activities” applications in its web portal. The main changes are: The addition of risk classes from...
by In2Pharma | May 14, 2019 | News
The Netherlands On 30 April 2019, the concept text for the Healthcare Transparency Register law was presented for consultation. With this concept law, the obligation for suppliers of medicines and medical devices to report financial relationships with healthcare...
by In2Pharma | Feb 6, 2018 | News
Belgium The Royal Decree of 15 November 2017 regarding the notification of a materiovigilance contact point and the registration of distributors and manufacturers of medical devices concerns the introduction of a new registration procedure that should limit the...
